中文名称: | DL-TBOA | ||||
---|---|---|---|---|---|
英文名称: | DL-TBOA | ||||
别名: | DL-TBOA DL-TBOA | ||||
CAS No: | 205309-81-5 | 分子式: | C11H13NO5 | 分子量: | 239.22 |
CAS No: | 205309-81-5 | ||||
分子式: | C11H13NO5 | ||||
分子量: | 239.22 |
基本信息
产品编号: |
D11020 |
||||
产品名称: |
DL-TBOA |
||||
CAS: |
205309-81-5 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
239.22 |
-20℃ |
1个月 |
||
化学名: |
|||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
4.1803mL |
20.9013mL |
41.8025mL |
5mM |
0.8361mL |
4.1803mL |
8.3605mL |
10mM |
0.4180mL |
2.0mL |
4.1803mL |
生物活性
产品描述 |
一种有效的不可运输的兴奋性氨基酸转运蛋白抑制剂。 |
|
靶点 |
IC50:70μM (EAAT1),6μM (EAAT2) and 6μM (EAAT3);Ki:42μM (human EAAT1),5.7μM (human EAAT2),4.4μM (EAAT4) and 3.2μM (EAAT5) |
|
体外研究 |
DL-TBOA (70-350μM;48 hours;HCT116 and LoVo cell lines) treatment concentration-dependently enhances SN38-induced loss of viability. DL-TBOA reversed Oxaliplatin-induced loss of viability.DL-TBOA (350μM;24 hours;HCT116 and LoVo cell lines) treatment decreases p53 induction by SN38 and oxaliplatin. Cell Viability Assay |
|
Cell Line: |
HCT116 and LoVo cell lines |
|
Concentration: |
70μM,350μM |
|
Incubation Time: |
48 hours |
|
Result: |
Enhanced SN38-induced, and counteracted Oxaliplatin-induced, cell death. |
|
Cell Viability Assay |
||
Cell Line: |
CT116 and LoVo cell lines |
|
Concentration: |
350μM |
|
Incubation Time: |
24 hours |
|
Result: |
p53 induction by SN38 and oxaliplatin was decreased. |
|
体内研究 |
DL-TBOA (10nmol;i.c.v.) to morphine-dependent rats significantly facilitates the expression of naloxone-precipitated somatic signs and conditioned place aversion. |
|
Animal Model: |
Male Sprague-Dawley rats (180-250g) |
|
Dosage: |
1nmol,3nmol,10nmol |
|
Administration: |
Intracerebroventricularly injection (i.c.v.) |
|
Result: |
Dose dependently facilitated various somatic signs induced by Naloxone (0.1mg/kg)- precipitated morphine withdrawal. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )